As part of the evaluation of the EANM’s eligibility for involvement in the activities of EMA, the following financial information is provided for EMA’s assessment (data pertaining to the financial year 2020):
Split of non-industry income (in % of total income)
- Royalties scientific journals: 2.82%
- Membership fees: 13.08%
- Registration fees: 29.05%
- Donations: 0.98%
- EU project funding: 0.47%
- Other income: 2.48%
Split of industry income (in % of total income)
- Congress and educational events: 44.03%
- Corporate membership: 7.39%
The highest contribution from a single company is 5.50% of the overall income.
The overall proportion of industry vs non-industry income in 2020 was 51.42% vs 48.95%.
It has to be noted that the ongoing pandemic and the need to cancel physical events have had a significant impact on the EANM’s finances in the past two years. Due to the decrease in turnover (e.g. registration fees from individual participants), the percentages of the various types of income changed substantially.
Industry partners 2020
The following companies provided financial contributions to the EANM.
Avid Radiopharmaceuticals (Lilly)
Avid Radiopharmaceuticals Inc.
Bayer Healthcare Pharmaceuticals, Inc
Blue Earth Diagnostic Ltd
Boston Scientific International
Cyclomedica Europe Ltd
Eczacibasi-Monrol Nuclear Products Co.
Isotope Technologies Dresden GmbH
Isotopia Molecular Imaging Ltd.
MiE Medical Imaging Electronics GmbH
NRG Advanced Nuclear Medicine
RI-Te Radiation Imaging Technologies
Shine Medical Technologies LLC
Sirtex Medical Europe
Sumitomo Heavy Industries
TEMA Synergi SpA
The Oncidium Foundation
US Dept of Energy Isotope Program
Wallonia Export & Investment